Abstract:Background: Drug-resistant epilepsy (DRE) is a refractory neurological disorder. There is ample evidence that suggest that γ-aminobutyric acid-a (GABAA) receptors could be one of the mechanisms responsible for the development of drug resistance in epilepsy. It is also known that the cAMP response element binding protein (CREB) plays a possible key role in the transcriptional regulation of GABAA. background: Drug-resistant epilepsy (DRE) is a refractory neurological disorder. There is ample evidence that suggest that γ-aminobutyric acid-a (GABAA) receptors could be one of the mechanisms responsible for the development of drug resistance in epilepsy. It is also known that the cAMP response element binding protein (CREB) plays a possible key role in the transcriptional regulation of GABAA. Objective: This study explores the role of CREB in the development of DRE and the effect of CREB on GABA-related receptors in DRE. objective: This study explores the role of CREB in the development of DRE and the effect of CREB on GABA-related receptors in DRE. Methods: The CREB expression was increased or decreased in the hippocampus of normal rats by lentiviral transfection, who then underwent the lithium-pilocarpine-induced epilepsy model. Phenobarbital (PB) sodium and carbamazepine (CBZ) were used to select a drug-resistant epileptic model. The expression levels of GABAA receptor α1, β2, and γ2 subunits and CREB protein were measured in the rat hippocampus by western blot and fluorescent quantitative PCR. method: The CREB expression was increased or decreased in the hippocampus of normal rats by lentiviral transfection who then underwent the lithium-pilocarpine-induced epilepsy model. Phenobarbital (PB) sodium and carbamazepine (CBZ) were used to select a drug-resistant epileptic model. The expression levels of GABAA receptor α1, β2, and γ2 subunits and CREB protein were measured in the rat hippocampus by western blot and fluorescent quantitative PCR. Results: The frequency and duration of seizures increased in the overexpression group compared to that in the control group. In addition, the severity, frequency, and duration of seizures decreased in the group with decreased expression. The hippocampus analysis of the expression levels of the CREB protein and CREB mRNA yielded similar findings. Altering the CREB protein expression in the rat hippocampus could negatively regulate the expression and transcript levels of GABAA receptors α1, β2, and γ2, suggesting that CREB may serve as a potential target for the development of treatment protocols and drugs for epilepsy. result: The frequency and duration of seizures increased in the overexpression group compared to that in the control group. In addition, the severity, frequency, and duration of seizures decreased in the group with decreased expression. The hippocampus analysis of the expression levels of the CREB protein and CREB mRNA yielded similar findings. Altering the CREB protein expression in the rat hippocampus could negatively regulate the expression and transcript levels of GABAA receptors α1, β2, and γ2, suggesting that CREB may serve as a potential target for the development of treatment protocols and drugs for epilepsy. Conclusion: Our study shows that enhanced CREB expression promotes the development of DRE and negatively regulates GABAA receptor levels and that the inhibition of CREB expression may reduce the incidence of DRE. conclusion: Our study shows that enhanced CREB expression promotes the development of DRE and negatively regulates GABAA receptor levels and that the inhibition of CREB expression may reduce the incidence of DRE. other: By investigating the role of CREB in the occurrence and development of DRE, this study may help other researchers in exploring whether CREB can be a new target for anti-seizure drugs.

A Novel Epigenetic Marker, Ten-eleven Translocation Family Member 2 (TET2), is Identified in the Intractable Epileptic Brain and Regulates ATP Binding Cassette Subfamily B Member 1 (ABCB1) in the Blood–brain Barrier

miR-485's anti-drug resistant epilepsy effects by regulating SV2A/PSD-95 and targeting ABCC1 and neuronal signaling-transduction proteins in hippocampus of rats

A Novel Function of TET2 in CNS: Sustaining Neuronal Survival

Abnormal Weakening of DNA Methylation around the SLC6A1 Gene Promoter in Temporal Lobe Epilepsy

Dysregulation Of Mir-1304-3p In Hippocampus And Serum Of Patients With Intractable Epilepsy

Alterations in DNA 5-hydroxymethylation patterns in the hippocampus of an experimental model of chronic epilepsy

Increased Cyclic Adenosine Monophosphate Responsive Element is Closely Associated with the Pathogenesis of Drug-resistant Epilepsy

Tet2 Downregulation Leads To Aml Cells Sensitive To Decitabine

TET2 regulates extranodal NK/T cell lymphoma progression through regulation of DNA methylation

CpG Methylation Signature Define Human Temporal Lobe Epilepsy and Predict Drug-Resistant

Systems-level Analysis Identifies Key Regulators Driving Epileptogenesis in Temporal Lobe Epilepsy.

TET3 is a positive regulator of mitochondrial respiration in Neuro2A cells

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility

Identification of gene regulatory networks affected across drug-resistant epilepsies

Tet3 ablation in adult brain neurons increases anxiety-like behavior and regulates cognitive function in mice

Serum biomarkers in patients with drug-resistant epilepsy: a proteomics-based analysis

A novel mutation of DNA2 regulates neuronal cell membrane potential and epileptogenesis

Status epilepticus triggers early and late alterations in brain-derived neurotrophic factor and NMDA glutamate receptor Grin2b DNA methylation levels in the hippocampus

The Suppression of Epileptiform Discharges in Cultured Hippocampal Neurons is Regulated Via Alterations in Full‐length Tropomyosin‐related Kinase Type B Receptors Signalling Activity

The m6A reader YTHDC2 promotes the pathophysiology of temporal lobe epilepsy by modulating SLC7A11-dependent glutamate dysregulation in astrocytes

Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy